APO Research
Talk to an analyst

APO RESEARCH · REPORT

In Vitro Diagnostics (IVDs) Products Contract Manufacturing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Analysis and Forecast 2026-2032

3 May 2026251 pages

Choose your research edition.

Industry ResearchIn Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal In Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Analysis and Forecast 2026-2032251 pages · $4,950 USD

Market perspective

The global In Vitro Diagnostics (IVDs) Products Contract Manufacturing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for In Vitro Diagnostics (IVDs) Products Contract Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for In Vitro Diagnostics (IVDs) Products Contract Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for In Vitro Diagnostics (IVDs) Products Contract Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for In Vitro Diagnostics (IVDs) Products Contract Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of In Vitro Diagnostics (IVDs) Products Contract Manufacturing include Jabil Inc., Sanmina Corporation, TE Connectivity, Savyon Diagnostics, West Pharmaceutical Services, Inc., Thermofisher, Celestica Inc., Biofortuna and Invetech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for In Vitro Diagnostics (IVDs) Products Contract Manufacturing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of In Vitro Diagnostics (IVDs) Products Contract Manufacturing, also provides the revenue of main regions and countries. Of the upcoming market potential for In Vitro Diagnostics (IVDs) Products Contract Manufacturing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the In Vitro Diagnostics (IVDs) Products Contract Manufacturing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global In Vitro Diagnostics (IVDs) Products Contract Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for In Vitro Diagnostics (IVDs) Products Contract Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

In Vitro Diagnostics (IVDs) Products Contract Manufacturing Segment by Company

Jabil Inc.

Sanmina Corporation

TE Connectivity

Savyon Diagnostics

West Pharmaceutical Services, Inc.

Thermofisher

Celestica Inc.

Biofortuna

Invetech

Cenogenics Corporation

In-Vitro Diagnostic Developers Inc

Maxim Biomedical, Inc

Elbit Systems Ltd. (KMC Systems, Inc.)

Nova Biomedical

LRE Medical

Cone Bioproducts

Biokit S.A.

Avioq, Inc

TCS Biosciences Ltd

Affinity Life Sciences, Inc

Coris BioConcept

Meridian Bioscience, Inc.

Merck KGaA

In Vitro Diagnostics (IVDs) Products Contract Manufacturing Segment by Type

IVD Consumables

IVD Equipment

In Vitro Diagnostics (IVDs) Products Contract Manufacturing Segment by Application

Assay Development Services

Manufacturing Services

Others

In Vitro Diagnostics (IVDs) Products Contract Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Diagnostics (IVDs) Products Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In Vitro Diagnostics (IVDs) Products Contract Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Diagnostics (IVDs) Products Contract Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of In Vitro Diagnostics (IVDs) Products Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of In Vitro Diagnostics (IVDs) Products Contract Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In Vitro Diagnostics (IVDs) Products Contract Manufacturing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. IVD Consumables Major Player Table 3. IVD Equipment Major Player Table 4. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Assay Development Services Major Player Table 6. Manufacturing Services Major Player Table 7. Others Major Player Table 8. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Trends Table 9. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Drivers Table 10. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Opportunities and Challenges Table 11. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Restraints Table 12. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Share by Region (2021-2026) Table 15. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Share by Region (2027-2032) Table 17. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share by Players (2021-2026) Table 19. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Key Players Headquarters & Area Served Table 21. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Players, Product Type & Application Table 22. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share by Type (2021-2026) Table 29. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share by Type (2027-2032) Table 30. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share by Application (2021-2026) Table 34. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share by Application (2027-2032) Table 35. Jabil Inc. Company Information Table 36. Jabil Inc. Business Overview Table 37. Jabil Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Jabil Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 39. Jabil Inc. Recent Development Table 40. Sanmina Corporation Company Information Table 41. Sanmina Corporation Business Overview Table 42. Sanmina Corporation In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sanmina Corporation In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 44. Sanmina Corporation Recent Development Table 45. TE Connectivity Company Information Table 46. TE Connectivity Business Overview Table 47. TE Connectivity In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. TE Connectivity In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 49. TE Connectivity Recent Development Table 50. Savyon Diagnostics Company Information Table 51. Savyon Diagnostics Business Overview Table 52. Savyon Diagnostics In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Savyon Diagnostics In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 54. Savyon Diagnostics Recent Development Table 55. West Pharmaceutical Services, Inc. Company Information Table 56. West Pharmaceutical Services, Inc. Business Overview Table 57. West Pharmaceutical Services, Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. West Pharmaceutical Services, Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 59. West Pharmaceutical Services, Inc. Recent Development Table 60. Thermofisher Company Information Table 61. Thermofisher Business Overview Table 62. Thermofisher In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Thermofisher In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 64. Thermofisher Recent Development Table 65. Celestica Inc. Company Information Table 66. Celestica Inc. Business Overview Table 67. Celestica Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Celestica Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 69. Celestica Inc. Recent Development Table 70. Biofortuna Company Information Table 71. Biofortuna Business Overview Table 72. Biofortuna In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Biofortuna In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 74. Biofortuna Recent Development Table 75. Invetech Company Information Table 76. Invetech Business Overview Table 77. Invetech In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Invetech In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 79. Invetech Recent Development Table 80. Cenogenics Corporation Company Information Table 81. Cenogenics Corporation Business Overview Table 82. Cenogenics Corporation In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Cenogenics Corporation In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 84. Cenogenics Corporation Recent Development Table 85. In-Vitro Diagnostic Developers Inc Company Information Table 86. In-Vitro Diagnostic Developers Inc Business Overview Table 87. In-Vitro Diagnostic Developers Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. In-Vitro Diagnostic Developers Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 89. In-Vitro Diagnostic Developers Inc Recent Development Table 90. Maxim Biomedical, Inc Company Information Table 91. Maxim Biomedical, Inc Business Overview Table 92. Maxim Biomedical, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Maxim Biomedical, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 94. Maxim Biomedical, Inc Recent Development Table 95. Elbit Systems Ltd. (KMC Systems, Inc.) Company Information Table 96. Elbit Systems Ltd. (KMC Systems, Inc.) Business Overview Table 97. Elbit Systems Ltd. (KMC Systems, Inc.) In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Elbit Systems Ltd. (KMC Systems, Inc.) In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 99. Elbit Systems Ltd. (KMC Systems, Inc.) Recent Development Table 100. Nova Biomedical Company Information Table 101. Nova Biomedical Business Overview Table 102. Nova Biomedical In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Nova Biomedical In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 104. Nova Biomedical Recent Development Table 105. LRE Medical Company Information Table 106. LRE Medical Business Overview Table 107. LRE Medical In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. LRE Medical In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 109. LRE Medical Recent Development Table 110. Cone Bioproducts Company Information Table 111. Cone Bioproducts Business Overview Table 112. Cone Bioproducts In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Cone Bioproducts In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 114. Cone Bioproducts Recent Development Table 115. Biokit S.A. Company Information Table 116. Biokit S.A. Business Overview Table 117. Biokit S.A. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Biokit S.A. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 119. Biokit S.A. Recent Development Table 120. Avioq, Inc Company Information Table 121. Avioq, Inc Business Overview Table 122. Avioq, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Avioq, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 124. Avioq, Inc Recent Development Table 125. TCS Biosciences Ltd Company Information Table 126. TCS Biosciences Ltd Business Overview Table 127. TCS Biosciences Ltd In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. TCS Biosciences Ltd In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 129. TCS Biosciences Ltd Recent Development Table 130. Affinity Life Sciences, Inc Company Information Table 131. Affinity Life Sciences, Inc Business Overview Table 132. Affinity Life Sciences, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Affinity Life Sciences, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 134. Affinity Life Sciences, Inc Recent Development Table 135. Coris BioConcept Company Information Table 136. Coris BioConcept Business Overview Table 137. Coris BioConcept In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Coris BioConcept In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 139. Coris BioConcept Recent Development Table 140. Meridian Bioscience, Inc. Company Information Table 141. Meridian Bioscience, Inc. Business Overview Table 142. Meridian Bioscience, Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Meridian Bioscience, Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 144. Meridian Bioscience, Inc. Recent Development Table 145. Merck KGaA Company Information Table 146. Merck KGaA Business Overview Table 147. Merck KGaA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Merck KGaA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio Table 149. Merck KGaA Recent Development Table 150. North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 151. North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 152. North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 153. North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 154. North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 156. North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 157. Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 158. Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 159. Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 160. Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 161. Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 163. Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 164. China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 165. China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 166. China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 167. China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 168. Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 171. Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Region (US$ Million) & (2021-2026) Table 174. Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Region (US$ Million) & (2027-2032) Table 175. SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 176. SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 177. SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 178. SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 179. SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 181. SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Image Figure 2. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size Share 2021 VS 2025 VS 2032 Figure 4. IVD Consumables Image Figure 5. IVD Equipment Image Figure 6. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Assay Development Services Image Figure 9. Manufacturing Services Image Figure 10. Others Image Figure 11. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size (US$ Million) & (2021-2032) Figure 12. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share by Type (2021-2032) Figure 19. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share by Application (2021-2032) Figure 22. North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Type (2021-2032) Figure 24. North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Application (2021-2032) Figure 25. North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Country (2021-2032) Figure 26. United States In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Type (2021-2032) Figure 31. Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Application (2021-2032) Figure 32. Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Country (2021-2032) Figure 33. Germany In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Type (2021-2032) Figure 43. China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Application (2021-2032) Figure 44. Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Type (2021-2032) Figure 46. Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Application (2021-2032) Figure 47. Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Region (2021-2032) Figure 48. Japan In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Type (2021-2032) Figure 56. SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Application (2021-2032) Figure 57. SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Country (2021-2032) Figure 58. Brazil In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • IVD Consumables
  • IVD Equipment
Applications
  • Assay Development Services
  • Manufacturing Services
  • Others
Companies covered
  • Jabil Inc.
  • Sanmina Corporation
  • TE Connectivity
  • Savyon Diagnostics
  • West Pharmaceutical Services, Inc.
  • Thermofisher
  • Celestica Inc.
  • Biofortuna
  • Invetech
  • Cenogenics Corporation
  • In-Vitro Diagnostic Developers Inc
  • Maxim Biomedical, Inc
  • Elbit Systems Ltd. (KMC Systems, Inc.)
  • Nova Biomedical
  • LRE Medical
  • Cone Bioproducts
  • Biokit S.A.
  • Avioq, Inc
  • TCS Biosciences Ltd
  • Affinity Life Sciences, Inc
  • Coris BioConcept
  • Meridian Bioscience, Inc.
  • Merck KGaA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market by Type
  3. 1.2.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 IVD Consumables
  5. 1.2.3 IVD Equipment
  6. 1.3 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market by Application
  7. 1.3.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Assay Development Services
  9. 1.3.3 Manufacturing Services
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Dynamics
  1. 2.1 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Trends
  2. 2.2 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Drivers
  3. 2.3 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Opportunities and Challenges
  4. 2.4 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Perspective (2021-2032)
  2. 3.2 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Growth Trends by Region
  3. 3.2.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Region (2021-2026)
  5. 3.2.3 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Players
  2. 4.1.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Players (2021-2026)
  3. 4.1.2 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Key Players Headquarters & Area Served
  7. 4.4 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Players, Product Type & Application
  8. 4.5 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market CR5 and HHI
  11. 4.6.3 2025 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Tier 1, Tier 2, and Tier 3
5 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Type
  1. 5.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2032)
  3. 5.3 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share by Type (2021-2032)
6 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Application
  1. 6.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2032)
  3. 6.3 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Jabil Inc.
  2. 7.1.1 Jabil Inc. Company Information
  3. 7.1.2 Jabil Inc. Business Overview
  4. 7.1.3 Jabil Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Jabil Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  6. 7.1.5 Jabil Inc. Recent Developments
  7. 7.2 Sanmina Corporation
  8. 7.2.1 Sanmina Corporation Company Information
  9. 7.2.2 Sanmina Corporation Business Overview
  10. 7.2.3 Sanmina Corporation In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sanmina Corporation In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  12. 7.2.5 Sanmina Corporation Recent Developments
  13. 7.3 TE Connectivity
  14. 7.3.1 TE Connectivity Company Information
  15. 7.3.2 TE Connectivity Business Overview
  16. 7.3.3 TE Connectivity In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 TE Connectivity In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  18. 7.3.5 TE Connectivity Recent Developments
  19. 7.4 Savyon Diagnostics
  20. 7.4.1 Savyon Diagnostics Company Information
  21. 7.4.2 Savyon Diagnostics Business Overview
  22. 7.4.3 Savyon Diagnostics In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Savyon Diagnostics In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  24. 7.4.5 Savyon Diagnostics Recent Developments
  25. 7.5 West Pharmaceutical Services, Inc.
  26. 7.5.1 West Pharmaceutical Services, Inc. Company Information
  27. 7.5.2 West Pharmaceutical Services, Inc. Business Overview
  28. 7.5.3 West Pharmaceutical Services, Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 West Pharmaceutical Services, Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  30. 7.5.5 West Pharmaceutical Services, Inc. Recent Developments
  31. 7.6 Thermofisher
  32. 7.6.1 Thermofisher Company Information
  33. 7.6.2 Thermofisher Business Overview
  34. 7.6.3 Thermofisher In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Thermofisher In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  36. 7.6.5 Thermofisher Recent Developments
  37. 7.7 Celestica Inc.
  38. 7.7.1 Celestica Inc. Company Information
  39. 7.7.2 Celestica Inc. Business Overview
  40. 7.7.3 Celestica Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Celestica Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  42. 7.7.5 Celestica Inc. Recent Developments
  43. 7.8 Biofortuna
  44. 7.8.1 Biofortuna Company Information
  45. 7.8.2 Biofortuna Business Overview
  46. 7.8.3 Biofortuna In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Biofortuna In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  48. 7.8.5 Biofortuna Recent Developments
  49. 7.9 Invetech
  50. 7.9.1 Invetech Company Information
  51. 7.9.2 Invetech Business Overview
  52. 7.9.3 Invetech In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Invetech In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  54. 7.9.5 Invetech Recent Developments
  55. 7.10 Cenogenics Corporation
  56. 7.10.1 Cenogenics Corporation Company Information
  57. 7.10.2 Cenogenics Corporation Business Overview
  58. 7.10.3 Cenogenics Corporation In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Cenogenics Corporation In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  60. 7.10.5 Cenogenics Corporation Recent Developments
  61. 7.11 In-Vitro Diagnostic Developers Inc
  62. 7.11.1 In-Vitro Diagnostic Developers Inc Company Information
  63. 7.11.2 In-Vitro Diagnostic Developers Inc Business Overview
  64. 7.11.3 In-Vitro Diagnostic Developers Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 In-Vitro Diagnostic Developers Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  66. 7.11.5 In-Vitro Diagnostic Developers Inc Recent Developments
  67. 7.12 Maxim Biomedical, Inc
  68. 7.12.1 Maxim Biomedical, Inc Company Information
  69. 7.12.2 Maxim Biomedical, Inc Business Overview
  70. 7.12.3 Maxim Biomedical, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Maxim Biomedical, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  72. 7.12.5 Maxim Biomedical, Inc Recent Developments
  73. 7.13 Elbit Systems Ltd. (KMC Systems, Inc.)
  74. 7.13.1 Elbit Systems Ltd. (KMC Systems, Inc.) Company Information
  75. 7.13.2 Elbit Systems Ltd. (KMC Systems, Inc.) Business Overview
  76. 7.13.3 Elbit Systems Ltd. (KMC Systems, Inc.) In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Elbit Systems Ltd. (KMC Systems, Inc.) In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  78. 7.13.5 Elbit Systems Ltd. (KMC Systems, Inc.) Recent Developments
  79. 7.14 Nova Biomedical
  80. 7.14.1 Nova Biomedical Company Information
  81. 7.14.2 Nova Biomedical Business Overview
  82. 7.14.3 Nova Biomedical In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Nova Biomedical In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  84. 7.14.5 Nova Biomedical Recent Developments
  85. 7.15 LRE Medical
  86. 7.15.1 LRE Medical Company Information
  87. 7.15.2 LRE Medical Business Overview
  88. 7.15.3 LRE Medical In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 LRE Medical In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  90. 7.15.5 LRE Medical Recent Developments
  91. 7.16 Cone Bioproducts
  92. 7.16.1 Cone Bioproducts Company Information
  93. 7.16.2 Cone Bioproducts Business Overview
  94. 7.16.3 Cone Bioproducts In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Cone Bioproducts In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  96. 7.16.5 Cone Bioproducts Recent Developments
  97. 7.17 Biokit S.A.
  98. 7.17.1 Biokit S.A. Company Information
  99. 7.17.2 Biokit S.A. Business Overview
  100. 7.17.3 Biokit S.A. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Biokit S.A. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  102. 7.17.5 Biokit S.A. Recent Developments
  103. 7.18 Avioq, Inc
  104. 7.18.1 Avioq, Inc Company Information
  105. 7.18.2 Avioq, Inc Business Overview
  106. 7.18.3 Avioq, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Avioq, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  108. 7.18.5 Avioq, Inc Recent Developments
  109. 7.19 TCS Biosciences Ltd
  110. 7.19.1 TCS Biosciences Ltd Company Information
  111. 7.19.2 TCS Biosciences Ltd Business Overview
  112. 7.19.3 TCS Biosciences Ltd In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  113. 7.19.4 TCS Biosciences Ltd In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  114. 7.19.5 TCS Biosciences Ltd Recent Developments
  115. 7.20 Affinity Life Sciences, Inc
  116. 7.20.1 Affinity Life Sciences, Inc Company Information
  117. 7.20.2 Affinity Life Sciences, Inc Business Overview
  118. 7.20.3 Affinity Life Sciences, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Affinity Life Sciences, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  120. 7.20.5 Affinity Life Sciences, Inc Recent Developments
  121. 7.21 Coris BioConcept
  122. 7.21.1 Coris BioConcept Company Information
  123. 7.21.2 Coris BioConcept Business Overview
  124. 7.21.3 Coris BioConcept In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Coris BioConcept In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  126. 7.21.5 Coris BioConcept Recent Developments
  127. 7.22 Meridian Bioscience, Inc.
  128. 7.22.1 Meridian Bioscience, Inc. Company Information
  129. 7.22.2 Meridian Bioscience, Inc. Business Overview
  130. 7.22.3 Meridian Bioscience, Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Meridian Bioscience, Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  132. 7.22.5 Meridian Bioscience, Inc. Recent Developments
  133. 7.23 Merck KGaA
  134. 7.23.1 Merck KGaA Company Information
  135. 7.23.2 Merck KGaA Business Overview
  136. 7.23.3 Merck KGaA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Merck KGaA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
  138. 7.23.5 Merck KGaA Recent Developments
8 North America
  1. 8.1 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue (2021-2032)
  2. 8.2 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2032)
  3. 8.2.1 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2026)
  4. 8.2.2 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2027-2032)
  5. 8.3 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Type (2021-2032)
  6. 8.4 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2032)
  7. 8.4.1 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2026)
  8. 8.4.2 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2027-2032)
  9. 8.5 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Application (2021-2032)
  10. 8.6 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country
  11. 8.6.1 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021-2026)
  13. 8.6.3 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue (2021-2032)
  2. 9.2 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2032)
  3. 9.2.1 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2026)
  4. 9.2.2 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2027-2032)
  5. 9.3 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Type (2021-2032)
  6. 9.4 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2032)
  7. 9.4.1 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2026)
  8. 9.4.2 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2027-2032)
  9. 9.5 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Application (2021-2032)
  10. 9.6 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country
  11. 9.6.1 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021-2026)
  13. 9.6.3 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue (2021-2032)
  2. 10.2 China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2032)
  3. 10.2.1 China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2026)
  4. 10.2.2 China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2027-2032)
  5. 10.3 China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Type (2021-2032)
  6. 10.4 China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2032)
  7. 10.4.1 China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2026)
  8. 10.4.2 China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2027-2032)
  9. 10.5 China In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue (2021-2032)
  2. 11.2 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2032)
  3. 11.2.1 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2026)
  4. 11.2.2 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2027-2032)
  5. 11.3 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Type (2021-2032)
  6. 11.4 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2032)
  7. 11.4.1 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2026)
  8. 11.4.2 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2027-2032)
  9. 11.5 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Application (2021-2032)
  10. 11.6 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country
  11. 11.6.1 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021-2026)
  13. 11.6.3 Asia In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue (2021-2032)
  2. 12.2 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Type (2027-2032)
  5. 12.3 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Application (2027-2032)
  9. 12.5 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country
  11. 12.6.1 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst